GetTopicDetailResponse(id=ac958034e42, topicName=耐受, introduction=耐受, content=null, image=null, comments=1, allHits=1485, url=https://h5.medsci.cn/topic?id=80347, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=12230, tagList=[TagDto(tagId=12230, tagName=耐受)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2113714, encodeId=53cd2113e1466, content=這僅是12周的結(jié)果，未來還需要觀察更長(zhǎng)時(shí)間，看是否存在<a href='/topic/show?id=ac958034e42' target=_blank style='color:#2F92EE;'>#耐受#</a>現(xiàn)象，甚至長(zhǎng)達(dá)1-2年的觀察，才能得出結(jié)論。另外，還要觀察血壓降低以后，伴隨的<a href='/topic/show?id=38c451e4317' target=_blank style='color:#2F92EE;'>#心血管事件#</a>是否同步降低，這也要新的臨床試驗(yàn)結(jié)果來說明！不過，對(duì)于<a href='/topic/show?id=9730986628b' target=_blank style='color:#2F92EE;'>#難治性高血壓#</a>，是<a href='/topic/show?id=9989e554530' target=_blank style='color:#2F92EE;'>#突破性進(jìn)展#</a>！, objectTitle=NEJM：Baxdrostat治療難治性高血壓的效果分析, objectType=article, longId=758111, objectId=e3fbe58111e4, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230202/1675300164870_1739456.jpg, objectUrl=/article/show_article.do?id=e3fbe58111e4, replyNumber=0, likeNumber=138, createdTime=2023-02-09, rootId=0, userName=showtest, userId=8f0715, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=e3fbe58111e4, moduleTitle=NEJM：Baxdrostat治療難治性高血壓的效果分析, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=e3fbe58111e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
